VANECK VECTORS ETF TR's ticker is GDX and the CUSIP is 92189F106. A total of 665 filers reported holding VANECK VECTORS ETF TR in Q3 2020. The put-call ratio across all filers is 1.01 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $859,694 | +62.2% | 31,947 | +45.3% | 0.00% | 0.0% |
| Q3 2022 | $530,000 | -80.3% | 21,981 | -77.7% | 0.00% | -75.0% |
| Q2 2022 | $2,694,000 | +233.8% | 98,393 | +290.7% | 0.00% | +300.0% |
| Q4 2021 | $807,000 | -99.3% | 25,186 | -99.3% | 0.00% | -99.1% |
| Q3 2021 | $111,173,000 | +4320.4% | 3,772,400 | +4775.2% | 0.12% | +2825.0% |
| Q1 2021 | $2,515,000 | +32.4% | 77,379 | +46.8% | 0.00% | +100.0% |
| Q4 2020 | $1,899,000 | -39.2% | 52,711 | -33.9% | 0.00% | -60.0% |
| Q3 2020 | $3,123,000 | +361.3% | 79,762 | +171.5% | 0.01% | +400.0% |
| Q1 2020 | $677,000 | -87.2% | 29,379 | -87.6% | 0.00% | -94.7% |
| Q1 2019 | $5,299,000 | – | 236,334 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Memorial Sloan Kettering Cancer Center | 738,500 | $20,220,000 | 66.82% |
| Baymount Management LP | 145,000 | $3,970,000 | 28.08% |
| New Harbor Financial Group, LLC | 1,371,341 | $37,547,000 | 18.51% |
| New Harbor Financial Group, LLC | 1,291,700 | $35,366,000 | 17.44% |
| MKP Capital Management, L.L.C. | 1,500,000 | $41,070,000 | 13.74% |
| Windmill Hill Asset Management Ltd | 844,600 | $23,125,000 | 11.94% |
| Hollow Brook Wealth Management LLC | 768,567 | $21,043,000 | 11.57% |
| Grand Central Investment Group | 261,915 | $7,171,000 | 10.33% |
| Point72 Europe (London) LLP | 1,467,000 | $40,166,000 | 8.50% |
| Slate Path Capital LP | 4,600,000 | $125,948,000 | 7.87% |